autologous skin fibroblasts
NA_00068684
Phase 2 mab active
Quick answer
autologous skin fibroblasts for Wounds and Injuries is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Wounds and Injuries
- Phase
- Phase 2
- Modality
- mab
- Status
- active